 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The firm intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Watchers	21
52-Wk Low	$0.15
52-Wk High	$6.10

Market Cap	$894,100.00
Volume (M)	590,684.00
52-Wk High	$6.10
52-Wk Low	$0.15

Current Price	$0.16
Prev Close	$0.16
Open	$0.1603
Dividend Yield	0.00%
50-Day Moving Average	$0.363
Beta	-0.52
Avg. Volume	79,020.48
PE Ratio	-0.06

52-Week High	$6.10
52-Week Low	$0.15
Market Capitalization	$894,100.00
EPS	-$2.64
Price to Book	0.40
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.13

CMNDF Clearmind Medicine Inc

About

Feed

News

Fundamentals